Herrmann Ken bought AKTS

July 20, 2026 · Form 4 insider transaction

Herrmann Ken bought 3,506 shares of Aktis Oncology, Inc. at $0.08 per share, a transaction worth $280.48. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.